Provided are beneficial and therapeutic Amanita muscaria compositions. In some embodiments, the provided A. muscaria compositions comprise A. muscaria extracts. In some embodiments, the provided A. muscaria compositions comprise one or more compounds from A. muscaria such as muscimol and muscarine, as well as analogs thereof. In some aspects, the provided A. muscaria compositions are used to promote health and wellness, such as to enhance calmness in a subject. In some aspects, the provided A. muscaria compositions are used to treat mental health conditions and physical health conditions in a subject.

Cannabinoid Alcoholic Drinks (CADs) and methods for producing CADs utilize cannabinoids dissolved in ethanol The resulting cannabinoid/ethanol solution is then combined with one or more consumable alcohols to create a CAD. Cannabidiol (CBD) can be selected as the cannabinoid, and the solution of CBD and ethanol is called CBD/ethanol solution and combining it with one or more consumable alcohols yields a CAD.

The present invention relates to a hepato-protective beverage composition comprising a potable liquid, a primary hepato-protective agent comprising 18-Glycyrrhizin or 18-Glycyrrhizin or a combination thereof, and a complimentary hepato-protective agent comprising sugar or sugar alcohol or a combination thereof. The combination of effective amounts of the primary and complimentary hepato-protective agents provides hepato-protection and reduced toxicity caused by consumption of alcoholic beverages. The present invention also provides a beverage additive comprising these hepato-protective agents designed to be mixed with a potable liquid, providing the same beneficial results.

The invention provides a novel PPAR activator, a pharmaceutical composition, a food or a drink, a food additive, a supplement and a method of producing these products. The PPAR activator includes an extract of a koji that contains 9-hydroxy-10,12-octadecadienoic acid (9-HODE: 10E, 12E) or an active fraction of the extract, as an active ingredient.

The present disclosure provides methods and systems for forming stable droplets as part of an emulsion. The emulsion may be, for example, formed by bringing an aqueous phase in contact with an oil phase at a droplet generation junction of a droplet generator. Droplets of the present disclosure may be used for holding compositions for various uses.

The present disclosure provides methods and systems for forming stable droplets as part of an emulsion. The emulsion may be, for example, formed by bringing an aqueous phase in contact with an oil phase at a droplet generation junction of a droplet generator. Droplets of the present disclosure may be used for holding compositions for various uses.

A method and system for making mugwort infused alcohol by providing a mugwort herb and an alcohol, and implementing infusion through a soaking technique, a steeping technique, and a mixing technique of the mugwort herb into the alcohol. The method further includes developing timelines for each of the soaking, steeping, and mixing techniques as well as testing an efficacy of the resultant admixture.

A method and system for making mugwort infused alcohol by providing a mugwort herb and an alcohol, and implementing infusion through a soaking technique, a steeping technique, and a mixing technique of the mugwort herb into the alcohol. The method further includes developing timelines for each of the soaking, steeping, and mixing techniques as well as testing an efficacy of the resultant admixture.

Medical cannabis such as edibles are used as a treatment option for (but is not limited to) a qualifying medical condition or a chronic medical condition which is severe and for which other treatments have been ineffective.

Medical cannabis such as edibles are used as a treatment option for (but is not limited to) a qualifying medical condition or a chronic medical condition which is severe and for which other treatments have been ineffective.